Need is still great for drug discovery; early adopters show AI tools can be used in big pharma. There are lots of applications of AI in managing care; a lot of back office applications including patient triaging. He does not see big AI mergers with pharma companies – this will be mainly...
Biotechnology and Biosciences Congress Valencia The 21st Biotechnology and Biosciences Congress is a celebration of innovation and exploration in the fields of biotechnology and biosciences, focusing on the theme 'Unleashing the Potential of Biotechnology... ConferenceMedical & Pharma Follow 6 ...
Hybrid Remote Work Full-Time Employee Boston, MA Lead global market access strategy, pricing, and value communications for a breakthrough medicine in autoimmune disease. Manage cross-functional teams and contribute to life-cycle strategy. 12+ years ofbiotech/pharma experience required. ...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List. 2024 Watch ListEditor / Curator-April 29, 2024 Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet. 2024 Watch ListEditor / Curator-April 27, 2024 GeoVax (GOVX) Launches Vaccine Manufacturing System. ...
November—19 companies November 29 - Kite Pharma: Gilead's cell therapy unit Kite Pharma is cutting staff as executives previewed a “refreshed business strategy." A spokesperson for Gilead confirmed the changes and said the cuts affect 7% of the workforce, however about 90 roles are being ...
Promoting trade between Korea and India companies TradeshowBuilding & ConstructionMedical & PharmaRenewable Energy Follow 5044.8 Mon, 02 - Tue, 03 Dec 2024 Pharmaceutical and Medical Meeting Planners' Summit (PMMP Summit) Renaissance Boston Waterfront Hotel, Boston 1254.8 Miles from Miami Beach Shifting...
Big Pharmas also joined the ranks of companies (repeatedly) laying off staff, with names such as Pfizer, Gilead, Novartis, Amgen, Bristol Myers Squibb and Johnson & Johnson all appearing on 2023’s Layoff Tracker. Related Fierce Biotech Layoff Tracker 2023: Reneo reduces wor...
Scheer Partners Senior Vice President Tim Conrey said the Quartermaster conversion will help companies solve for “speed to market” as demand for life science space in the region has been strong. Enlarge A diagram shows the buildings that are leased (gray) and the buildings that are available ...
What sets these 10 companies apart is that all but one of them have attracted foreign Big Pharma companies buying into their R&D—not the other way around. BeiGene hassigned onAmgen, Chi-Med has ongoing collaborations with Eli Lilly and AstraZeneca, and CStone Pharmaceuticals recentlylicensedChina...
SAARBRÜCKEN / VIENNA, 17-Feb-2021 — /EPR BIOTECH NEWS/ — In the fight against the SARS-CoV-2 virus, a large number of pharmaceutical companies are looking for new approaches to combat the pandemic. In addition to vaccines, intensive research and development efforts around...